These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 4920573)
1. Amantadine hydrochloride in the treatment of Parkinson's disease. Gilligan BS; Veale J; Wodak J Med J Aust; 1970 Oct; 2(14):634-7. PubMed ID: 4920573 [No Abstract] [Full Text] [Related]
2. Amantadine hydrochloride in the treatment of Parkinsonism. A controlled trial. Appleton DB; Eadie MJ; Sutherland JM Med J Aust; 1970 Oct; 2(14):626-9. PubMed ID: 4920572 [No Abstract] [Full Text] [Related]
3. Observations on the effect of amantadine hydrochloride in the treatment of Parkinsonism. Schwieger AC; Jenkins AC Med J Aust; 1970 Oct; 2(14):630-2. PubMed ID: 5477806 [No Abstract] [Full Text] [Related]
4. Combined treatment of parkinsonism with L-dopa and amantadine. Godwin-Austen RB; Frears CC; Bergmann S; Parkes JD; Knill-Jones RP Lancet; 1970 Aug; 2(7669):383-5. PubMed ID: 4194690 [No Abstract] [Full Text] [Related]
5. Treatment of Parkinson's Disease with levodopa and amantadine used as single drugs and in combined therapy. Callagham N; Mcllroy M; O'Connor M Ir J Med Sci; 1974 Mar; 143(2):67-78. PubMed ID: 4617744 [No Abstract] [Full Text] [Related]
6. Amantadine HCL (Symmetrel) and its relation to Levo-Dopa in the treatment of Parkinson's disease. Schwab RS; England AC Trans Am Neurol Assoc; 1969; 94():85-90. PubMed ID: 4907453 [No Abstract] [Full Text] [Related]
8. L-dopa and amantadine hydrochloride in Parkinson's disease. Parkes JD; Zilkha KJ; Knill-Jones RP; Clements PJ; Baxter R Int Z Klin Pharmakol Ther Toxikol; 1971 Apr; 4(3):356-60. PubMed ID: 4931417 [No Abstract] [Full Text] [Related]
9. Treatment of Parkinson's disease with amantadine and L-Dopa. Rinne UK; Sonninen V; Siirtola T Eur Neurol; 1972; 7(4):228-40. PubMed ID: 4556618 [No Abstract] [Full Text] [Related]
10. Double blind study using amantadine hydrochloride in the therapy of Parkinson's disease. Silver DE; Sahs AL Trans Am Neurol Assoc; 1971; 96():307-8. PubMed ID: 4945919 [No Abstract] [Full Text] [Related]
11. Controlled trial of amantadine hydrochloride in Parkinson's disease. Jorgensen PB; Bergin JD; Haas L; Cuningham JA; Morah DD; Pollock M; Robinson RG; Spears GF N Z Med J; 1971 May; 73(468):263-7. PubMed ID: 4932146 [No Abstract] [Full Text] [Related]
12. Amantadine in Parkinson's disease. Review of more than two years' experience. Schwab RS; Poskanzer DC; England AC; Young RR JAMA; 1972 Nov; 222(7):792-5. PubMed ID: 4677928 [No Abstract] [Full Text] [Related]
13. Controlled trial of amantadine hydrochloride in Parkinson's disease. Parkes JD; Calver DM; Zilkha KJ; Knill-Jones RP Lancet; 1970 Feb; 1(7641):259-62. PubMed ID: 4189290 [No Abstract] [Full Text] [Related]
14. Trial of amantadine in Parkinson's disease. Campbell AM; Williams MJ Br J Clin Pract; 1972 Jan; 26(1):19-22. PubMed ID: 4554563 [No Abstract] [Full Text] [Related]
15. Comparison of amantadine, placebo, and levodopa in Parkinson's disease. Bauer RB; McHenry JT Neurology; 1974 Aug; 24(8):715-20. PubMed ID: 4858417 [No Abstract] [Full Text] [Related]
16. A double-blind study of amantadine hydrochloride versus benztropine mesylate in drug-induced parkinsonism. Kelly JT; Zimmermann RL; Abuzzahab FS; Schiele BC Pharmacology; 1974; 12(2):65-73. PubMed ID: 4610599 [No Abstract] [Full Text] [Related]
17. The continued use of amantadine hydrochloride in parkinsonism. Appleton DB; Eadie MJ; Sutherland JM Med J Aust; 1971 Oct; 2(14):707-9. PubMed ID: 4939890 [No Abstract] [Full Text] [Related]